Merrimack Pharmaceuticals controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2019
SEC insider-trading charge involving Songjiang Wang
The United States Securities and Exchange Commission charged Songjiang Wang with insider trading in a separate proceeding.
2018
Securities-fraud conviction involving Songjiang Wang
Songjiang Wang, identified as Merrimack’s statistical programming director, was convicted of securities fraud and conspiracy to commit securities fraud. A United States district court imposed a six-month prison sentence and supervised release.